Summary
Medtronic plc filed an 8-K on February 23, 2021, to furnish its press release detailing third quarter fiscal year 2021 financial results. While the 8-K itself does not contain the detailed financial figures, it directs investors to the accompanying press release (Exhibit 99.1) for this information. This filing serves as the official notification and public dissemination of the company's quarterly performance, which is crucial for investors to assess the company's ongoing financial health, operational execution, and progress against its strategic objectives.
Key Highlights
- 1Medtronic plc announced its third quarter fiscal year 2021 financial results via a press release filed with the SEC.
- 2The 8-K filing serves as the official record of the company's quarterly earnings announcement.
- 3Investors are directed to Exhibit 99.1, the press release dated February 23, 2021, for detailed financial performance information.
- 4This filing is a routine disclosure, providing updates on the company's financial condition and operational results for the specified quarter.
- 5The press release would typically contain key metrics such as revenue, net income, earnings per share, and segment performance.
Frequently Asked Questions
The main purpose of this 8-K filing is to officially announce and make public Medtronic's financial results for its third quarter of fiscal year 2021, as detailed in the accompanying press release.
The actual financial results, including revenue, net income, and earnings per share, are located in the press release furnished as Exhibit 99.1 to this 8-K filing.
No, the 8-K filing document primarily serves to notify the public and direct them to the press release (Exhibit 99.1) where the detailed financial numbers and commentary are provided.
This report covers Medtronic's third quarter of fiscal year 2021.